Nanoparticles in Peritoneal Carcinomatosis
Journal Title: Journal of Clinical Medical Research - Year 2022, Vol 3, Issue 3
Abstract
The management of peritoneal metastasis remains controversial. The logo regional treatments are Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and recently the Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). Both methods were improved the survival and quality of life in precisions selected patients. On the other hand major progress has been made through nanoparticles. In this short review presented the use of nanoparticles a novel tool increase drug delivery and penetration and may be more effective in patients with peritoneal metastasis.
Authors and Affiliations
Spiliotis John1*, Spiliotis Nicolas-Jason1,2, Saroyan Hayarpi1
Successful Treatment of Granuloma Annulare with Tapinarof 1% Cream: A Case Report
Granuloma Annulare (GA) is an inflammatory, granulomatous skin condition that presents with erythematous plaques or papules with several subtypes including patch, perforating, subcutaneous and atypical. GA is benign and...
Lamelar Ichthyosis
Background: Lamellar Ichthyosis (LI) is a rare hereditary autosomal recessive disease with a defect in chromosome 14q11 which generates defect of transglutaminase-1 (TGM-1) enzyme. Clinical manifestation of IL is initi...
Low-Dose Oral Therapy of Pyridostigmine for the Treatment of Severe Side Effects from Botulinum Toxin Injection
Botulinum toxin is a potent neurotoxin that causes flaccid paralysis of muscles by blocking the release of acetylcholine at the neuromuscular junction, thus preventing muscle contraction. Injecting the toxin is a cosmeti...
Cementum: Composition, Formation and Regeneration
Cementum is forming a thin layer over the root. Incremental lines of Salter reflect periodic deposition, separating mixed cementum into successive layers. Cementum plays a role in the anchorage of the teeth and adaptativ...
Exertional Weakness Seen as An Important Clinical Manifestation in Female Carriers of Duchenne Muscular Dystrophy
Introduction: Duchenne Muscular Dystrophy is an X-linked recessive condition caused by dystrophin mutations. Case Presentation: Three unrelated women who were carrying a pathogenic dystrophin mutation were evaluated w...